Thomas H Fischer
Overview
Explore the profile of Thomas H Fischer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huttelmaier M, Gabel A, Herting J, Vogel M, Stork S, Frantz S, et al.
J Interv Card Electrophysiol
. 2025 Feb;
PMID: 39899140
Introduction: Atrial cardiomyopathy (AC) establishes links between atrial fibrillation (AF), left atrial (LA) mechanical dysfunction, structural remodeling, and thromboembolic events. Early diagnosis of AC may impact AF treatment and stroke...
2.
Huttelmaier M, Fischer T
Inn Med (Heidelb)
. 2024 Jul;
65(8):787-797.
PMID: 38977442
Genetic arrhythmia disorders are rare diseases; however, they are a common cause of sudden cardiac death in children, adolescents, and young adults. In principle, a distinction can be made between...
3.
Huttelmaier M, Munsterer S, Morbach C, Sahiti F, Scholz N, Albert J, et al.
PLoS One
. 2024 Apr;
19(4):e0302321.
PMID: 38635729
Aims: This study investigated whether an activated R-mode in patients carrying a cardiac implantable electronic device (CIED) is associated with worse prognosis during and after an episode of acutely decompensated...
4.
Seewald M, Huttelmaier M, Kriebel T, Fischer T
Eur Heart J Case Rep
. 2023 Nov;
7(11):ytad563.
PMID: 38034937
Background: In childhood and adolescence, cardiac arrhythmias are often benign in the absence of congenital heart defects. Nevertheless, life-threatening inherited arrhythmogenic syndromes can become clinically manifest in early childhood. As...
5.
Huttelmaier M, Gabel A, Seewald M, Jungbauer C, Frantz S, Stork S, et al.
PLoS One
. 2022 Aug;
17(8):e0269816.
PMID: 35960722
Objectives: The study aims to investigate the impact of COVID-19 pandemic on physical activity and frequency of implantable cardioverter-defibrillator (ICD) therapies of patients with cardiac implantable electronic devices. Methods And...
6.
Pabel S, Knierim M, Stehle T, Alebrand F, Paulus M, Sieme M, et al.
Circ Res
. 2022 Feb;
130(7):994-1010.
PMID: 35193397
Rationale: Atrial fibrillation (AF) and heart failure often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV)...
7.
Eiringhaus J, Wunsche C, Tirilomis P, Herting J, Bork N, Nikolaev V, et al.
ESC Heart Fail
. 2020 Jul;
7(5):2992-3002.
PMID: 32710603
Aims: Inhibition of neprilysin and angiotensin II receptor by sacubitril/valsartan (Val) (LCZ696) reduces mortality in heart failure (HF) patients compared with sole inhibition of renin-angiotensin system. Beneficial effects of increased...
8.
Fischer T
Dtsch Med Wochenschr
. 2020 Apr;
145(8):526-535.
PMID: 32294778
The use of medical antiarrhythmic therapy apart from beta-blockers has been steadily decreasing in the recent past. This can partly be attributed to technological progress that has rendered the ablation...
9.
Eiringhaus J, Herting J, Schatter F, Nikolaev V, Sprenger J, Wang Y, et al.
Basic Res Cardiol
. 2019 Feb;
114(2):13.
PMID: 30788598
Increased late sodium current (late I) is an important arrhythmogenic trigger in cardiac disease. It prolongs cardiac action potential and leads to an increased SR Ca leak. This study investigates...
10.
Tose Costa Paiva B, Fischer T, Brachmann J, Busch S
Clin Cardiol
. 2019 Jan;
42(3):400-405.
PMID: 30652321
Atrial fibrillation (AF) and heart failure (HF) are epidemic cardiac diseases and are often detected in the same patient. Recent evidence suggests that this is not a mere coincidence but...